The 4th International Electronic Conference on Cancers

School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia;
Distinguished Professor Magdalena Plebanski is an internationally- renowned leader in immunology and bioengineering research, Head of the Translational Immunology and Nanotechnology Theme, and Head of the Cancer, Ageing, and Vaccines Laboratory at School of Health and Biomedical Sciences. She is also Director of RMIT’s Biomedical and Health Innovation Enabling Impact Platform. Magdalena forged a stellar career in medical and health research. At Oxford University, she showed new ways in which malaria parasites trick the human immune system and pioneered vaccine modifications now widely used around the world. Magdalena globally changed the design of nanoparticle based vaccines, showing smaller sized particles improve immune responses. Currently, Magdalena interests lie in changing the extremely low survival outcomes from ovarian cancer, by identifying new diagnostic and prognostic biomarkers in the blood. One of her patented biomarkers currently underlies a large-scale Phase II human clinical trial across 15 hospitals around Australia. Magdalena and her team are also testing innovative gold-based immunotherapies in collaboration with RMIT chemists, as well as collaborating with RMIT nanoengineers to develop practical point-of-care diagnostic devices. Magdalena has published more than 200 peer-reviewed full-length papers, including in leading journals such as Lancet, Nature, Science, Immunity, Nature Biotechnology, Nature Medicine and Nature Communications among others. University Link: https://www.rmit.edu.au/contact/staff-contacts/academic-staff/p/plebanski-magdalena Linkedin: https://www.linkedin.com/in/magdalenaplebanski/ Google Scholar: https://scholar.google.co.in/citations?user=hMyXlrMAAAAJ&hl=en

Institute for Health and Sport, Victoria University, Melbourne, Australia;
Professor Kulmira Nurgali (PhD 2004, Melbourne University) is a research and teaching academic at the College of Health and Engineering, Institute for Health and Sport, Victoria University, Australia and an Honorary Associate Professor at the Department of Medicine, University of Melbourne, Australia. She is the Head of Enteric Neuropathy Laboratory at the Centre for Health, Research and Education, Sunshine Hospital, Melbourne, Australia and Director of the Stem Cells and Regenerative Medicine Program at the Australian Institute for Musculoskeletal Science. She has an internationally-recognized prominence in the fields of Enteric Neuroscience and Neurogastroenterology. Prof Nurgali’s research is focused on enteric neuropathy associated with Inflammatory Bowel Disease, colorectal cancer, and the side effects of chemotherapy. Being a medical graduate, she focuses on the development of novel treatments and pre-clinical studies that have translational value. Publications and research activity can be found via ORCID ID: 0000-0002-2597-6929. University Link: https://www.vu.edu.au/contact-us/kulmira-nurgali Linkedin: https://www.linkedin.com/in/kulmira-nurgali-82291124/ Google Scholar: https://scholar.google.co.in/citations?hl=en&user=oVtmgcgAAAAJ